DD114599A5 - - Google Patents

Info

Publication number
DD114599A5
DD114599A5 DD181291A DD18129174A DD114599A5 DD 114599 A5 DD114599 A5 DD 114599A5 DD 181291 A DD181291 A DD 181291A DD 18129174 A DD18129174 A DD 18129174A DD 114599 A5 DD114599 A5 DD 114599A5
Authority
DD
German Democratic Republic
Application number
DD181291A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD114599A5 publication Critical patent/DD114599A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD181291A 1973-09-26 1974-09-24 DD114599A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
DD114599A5 true DD114599A5 (cg-RX-API-DMAC10.html) 1975-08-12

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
DD181291A DD114599A5 (cg-RX-API-DMAC10.html) 1973-09-26 1974-09-24

Country Status (16)

Country Link
US (1) US3965128A (cg-RX-API-DMAC10.html)
JP (1) JPS5059362A (cg-RX-API-DMAC10.html)
AR (1) AR202946A1 (cg-RX-API-DMAC10.html)
AU (1) AU7374074A (cg-RX-API-DMAC10.html)
BE (1) BE820381A (cg-RX-API-DMAC10.html)
DD (1) DD114599A5 (cg-RX-API-DMAC10.html)
DE (1) DE2349024A1 (cg-RX-API-DMAC10.html)
DK (1) DK507974A (cg-RX-API-DMAC10.html)
FI (1) FI280574A7 (cg-RX-API-DMAC10.html)
FR (1) FR2244492A1 (cg-RX-API-DMAC10.html)
IL (1) IL45629A0 (cg-RX-API-DMAC10.html)
LU (1) LU70985A1 (cg-RX-API-DMAC10.html)
NL (1) NL7412747A (cg-RX-API-DMAC10.html)
NO (1) NO743449L (cg-RX-API-DMAC10.html)
SE (1) SE7412058L (cg-RX-API-DMAC10.html)
ZA (1) ZA746131B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
AU1399199A (en) * 1997-11-14 1999-06-07 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
EP1838296B1 (en) 2004-10-20 2012-08-08 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
EP2314295B1 (en) * 2005-07-29 2015-01-28 Resverlogix, Inc Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CN101641339B (zh) * 2007-02-01 2013-07-17 雷斯韦洛吉克斯公司 用于预防和治疗心血管疾病的化合物
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
US8952021B2 (en) 2009-01-08 2015-02-10 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
AU2010224523B2 (en) 2009-03-18 2014-05-08 Resverlogix Corp. Novel anti-inflammatory agents
MX374414B (es) 2009-04-22 2025-03-06 Resverlogix Corp Nuevos agentes anti-inflamatorios.
SI2773354T1 (sl) 2011-11-01 2019-08-30 Resverlogix Corp. Peroralne formulacije s takojšnjim sproščanjem za substituirane kinazolinone
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
CN105073744B (zh) 2012-12-21 2019-11-08 齐尼思表观遗传学有限公司 作为溴结构域抑制剂的新型杂环化合物
CN107530356A (zh) 2015-03-13 2018-01-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法

Also Published As

Publication number Publication date
DE2349024A1 (de) 1975-04-10
FI280574A7 (cg-RX-API-DMAC10.html) 1975-03-27
NL7412747A (nl) 1975-04-01
SE7412058L (cg-RX-API-DMAC10.html) 1975-03-27
AR202946A1 (es) 1975-07-31
US3965128A (en) 1976-06-22
JPS5059362A (cg-RX-API-DMAC10.html) 1975-05-22
NO743449L (cg-RX-API-DMAC10.html) 1975-04-28
AU7374074A (en) 1976-04-01
IL45629A0 (en) 1974-11-29
FR2244492A1 (cg-RX-API-DMAC10.html) 1975-04-18
BE820381A (fr) 1975-03-26
DK507974A (cg-RX-API-DMAC10.html) 1975-06-09
ZA746131B (en) 1975-09-24
LU70985A1 (cg-RX-API-DMAC10.html) 1975-03-06

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC10.html)
AU476761B2 (cg-RX-API-DMAC10.html)
AU465372B2 (cg-RX-API-DMAC10.html)
AR201235Q (cg-RX-API-DMAC10.html)
AR201231Q (cg-RX-API-DMAC10.html)
AU474593B2 (cg-RX-API-DMAC10.html)
AU474511B2 (cg-RX-API-DMAC10.html)
AU474838B2 (cg-RX-API-DMAC10.html)
AU471343B2 (cg-RX-API-DMAC10.html)
AU465453B2 (cg-RX-API-DMAC10.html)
AU465434B2 (cg-RX-API-DMAC10.html)
AU450229B2 (cg-RX-API-DMAC10.html)
AU476714B2 (cg-RX-API-DMAC10.html)
AR201229Q (cg-RX-API-DMAC10.html)
AU476696B2 (cg-RX-API-DMAC10.html)
AU466283B2 (cg-RX-API-DMAC10.html)
AU472848B2 (cg-RX-API-DMAC10.html)
AR199451A1 (cg-RX-API-DMAC10.html)
AU477823B2 (cg-RX-API-DMAC10.html)
AU471461B2 (cg-RX-API-DMAC10.html)
AU476873B1 (cg-RX-API-DMAC10.html)
AU447540B2 (cg-RX-API-DMAC10.html)
AR195311A1 (cg-RX-API-DMAC10.html)
AR195948A1 (cg-RX-API-DMAC10.html)
AR210729A1 (cg-RX-API-DMAC10.html)